Combimal 40/320mg 9 Capsules

Effective Treatment for Uncomplicated Malaria

Combimal 40/320mg is a fixed-dose Artemisinin-based Combination Therapy (ACT) used for the treatment of uncomplicated malaria caused by Plasmodium falciparum. It combines two powerful antimalarial agents to ensure rapid parasite clearance and reduce the risk of treatment failure.

Active Ingredients

Each capsule contains:

• Dihydroartemisinin (40mg): A fast-acting derivative that quickly reduces the malaria parasite load in the blood.
• Piperaquine Phosphate (320mg): A long-acting antimalarial that eliminates remaining parasites and provides post-treatment protection.

Indications and Use

Combimal is indicated for the treatment of malaria in adults and children. It is specifically formulated to:

• Provide rapid relief from malaria symptoms like fever, chills, and headache.
• Clear malaria parasites from the bloodstream within a short period.
• Prevent the recurrence of infection when the full course is completed.

Dosage and Administration

For effective results, Combimal must be taken according to a specific schedule:

• Standard Adult Dose: 3 capsules taken once daily for 3 consecutive days.
• It is recommended to take the medication at the same time each day.
• Always complete the full 3-day course, even if you feel better after the first dose, to prevent drug resistance.

Important Safety Information

• Diagnosis: Only use this medication after a confirmed malaria diagnosis (via RDT or microscopy).
• Medical Advice: Consult a doctor or GoMed pharmacist before use if you have underlying heart, liver, or kidney conditions.
• Pregnancy: If you are pregnant or breastfeeding, seek professional medical guidance before starting treatment.
• Side Effects: Common side effects may include mild nausea, dizziness, or headache. If you experience severe reactions, stop use and contact a healthcare provider immediately.

Store in a cool, dry place away from children.